These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Physiological bases and therapeutic uses of inodilator drugs]. Costa R, De Marino V, Marino A. Clin Ter; 1991 Jan 31; 136(2):85-94. PubMed ID: 1827377 [Abstract] [Full Text] [Related]
5. Hemodynamic support and the role of dopamine. Bellomo R, Cole L, Ronco C. Kidney Int Suppl; 1998 May 31; 66():S71-4. PubMed ID: 9573578 [Abstract] [Full Text] [Related]
10. The role of novel inotropic agents in the treatment of heart failure. LeJemtel TH, Keren G, Reis D, Sonnenblick EH. J Cardiovasc Pharmacol; 1986 Nov 14; 8 Suppl 9():S47-54. PubMed ID: 2433542 [Abstract] [Full Text] [Related]
14. Enoximone and milrinone--inotropic vasodilators for severe heart failure. Drug Ther Bull; 1991 May 13; 29(10):39-40. PubMed ID: 1834448 [No Abstract] [Full Text] [Related]
18. Effects of epinephrine, norepinephrine, magnesium sulfate, and milrinone on survival and the occurrence of arrhythmias in amitriptyline poisoning in the rat. Knudsen K, Abrahamsson J. Crit Care Med; 1994 Nov 13; 22(11):1851-5. PubMed ID: 7956291 [Abstract] [Full Text] [Related]